Cholestasis
-
Subject Areas on Research
- ACR Appropriateness Criteria® Radiologic Management of Biliary Obstruction.
- AIDS cholangiopathy as the first sign of HIV infection.
- Amoxicillin-Clavulanate-Induced Liver Injury.
- Arthrogryposis, renal tubular acidosis and cholestasis syndrome: spectrum of the clinical manifestations.
- Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.
- Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy.
- Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation.
- Case report. Intrabiliary colonic metastasis mimicking primary biliary neoplasia.
- Current management of biliary strictures.
- Cystic duct patency in malignant obstructive jaundice. An ERCP-based study relevant to the role of laparoscopic cholecystojejunostomy.
- Delivery catheter entrapment during deployment of expandable metal stents.
- Endoscopic nasobiliary drain placement facilitates subsequent percutaneous transhepatic cholangiography.
- Gastric xanthomatosis and cholestasis. A causal relationship.
- Gastroduodenal artery pseudoaneurysm presenting with obstructive jaundice.
- Gastrointestinal case of the day. Mirizzi syndrome.
- Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
- High rates of recurrent biliary tract obstruction in children with sickle cell disease.
- Influence of weight at enterostomy reversal on surgical outcomes in infants after emergent neonatal stoma creation.
- Inhibition of bile flow by intravenous arginine hydrochloride.
- Jaundice. Value of five-day steroid test in differential diagnosis.
- Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats.
- Liver disease in pregnancy.
- Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
- MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
- Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability.
- Mucolipidosis II (I-cell disease) presenting as neonatal cholestasis.
- Multicenter randomized trial of the spiral Z-stent compared with the Wallstent for malignant biliary obstruction.
- Obstruction of the Biliary and Urinary System.
- Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
- Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.
- Percutaneous Management of Benign Biliary Strictures with Large-Bore Catheters: Comparison between Patients with and without Orthotopic Liver Transplantation.
- Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
- Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline.
- Pregnancy outcomes associated with viral hepatitis.
- Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage.
- Pruritus in systemic disease: mechanisms and management.
- Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents.
- Renal tubular insufficiency, cholestatic jaundice, and multiple congenital anomalies--a new multisystem syndrome.
- Reply to: "Percutaneous Management of Benign Biliary Strictures: Is It Time to Focus on Reducing Procedure Invasiveness?".
- Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
- Smoothened is a master regulator of adult liver repair.
- Somatostatin-induced cholestasis can be independent of portal blood flow.
- Tetracycline-induced bile duct paucity and prolonged cholestasis.
- The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
- The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
- Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver.
-
Keywords of People
- Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology